Funding
The Research carried out at Inserm UMR 1096 benefits from the following sources of public funding and sponsors:
General funds:
Targeted funding:
ERA-CVD: LYMIT-DIS
EU FP7: FIBRO-TARGETS
European Cooperation in Science and Technology (COST) program BM1301 ADMIRE
Fondation de la Recherche Medicale:
